(secondQuint)A Phase II Study for Patients With Indolent Non-follicular Non-Hodgkin's Lymphoma.

 This is a prospective, multicenter phase II trial designed to determine efficacy and safety of a chemoimmunotherapy with the combination of Bendamustine + Rituximab in patients with advanced untreated Indolent non Follicular non-Hodgkin Lymphomas (INFL).

 The study includes and induction phase and a consolidation phase.

.

 A Phase II Study for Patients With Indolent Non-follicular Non-Hodgkin's Lymphoma@highlight

This is a prospective, multicenter phase II trial designed to determine efficacy and safety of a chemoimmunotherapy with the combination of Bendamustine + Rituximab in patients with advanced untreated Indolent non Follicular non-Hodgkin Lymphomas (INFL).

